In August 2011 the FDA issued a safety communication recommending that the extremely popular antidepressant citalopram (Celexa) not be used at doses greater than 40 mg/day because of a potential increased risk for serious cardiac arrhythmias associated with prolongation of the QT interval. Now a study published in BMJ lends support to this warning and suggests that…
Popular Antidepressants May Put Patients At Risk For Serious Arrhythmias
January 29, 2013 by 1 Comment
Recent Comments